US 11026939
High dosage valbenazine formulation and compositions, methods, and kits related thereto
granted A61KA61K31/4745A61K47/02
Quick answer
US patent 11026939 (High dosage valbenazine formulation and compositions, methods, and kits related thereto) held by Neurocrine Biosciences, Inc. expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K31/4745, A61K47/02, A61K47/12, A61K47/26